More than 150 years have elapsed since endometriosis was discovered and described. Yet, until now, no scholarly history has ever been written about the disease, which affects millions of women worldwide.
Butler auditorium sits vacant on an August afternoon, awaiting a fresh wave of students to fill its seats in the upcoming fall semester. When a bevy of new faces finally greet this room and cycle through these seats once again, one surefire constant will remain: Dr. Murray Ettinger will be here to help them.
Elie A. Akl, MD, PhD, recently served as guideline methodologist for the World Health Organization's recommendations to decrease HIV/AIDS rates among men who have sex with men and transgender individuals.
Mark J. Lema, MD, PhD ’78, professor and chair of the Department of Anesthesiology, will become only the 65th physician in the ASA’s century-plus history to receive its highest tribute for service and achievement.
An announcement at the American Society of Clinical Oncology annual meeting that the drug exemestane significantly reduces the risk of breast cancer in high-risk, postmenopausal women is the result of a clinical trial in which UB researchers and women in Western New York played a critical role.
The National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) has stopped the AIM-HIGH clinical research trial 18 months earlier than planned due to lack of efficacy in reducing cardiovascular events.
The honored speaker at the 2011 commencement for the Biomedical Sciences was Constance Brinckerhoff, PhD ’68, Nathan Smith Professor of Molecular Medicine and Biochemistry, and associate dean of science at the Dartmouth Medical School.